 |
Spero Therapeutics
Last updated: July 29, 2024
CEO Ankit Mahadevia
USA | Funding: $443.6M (+)
Website: https://sperotherapeutics.com/
As a multi-asset, clinical-stage biopharmaceutical company, Spero Therapeutics is focused on identifying, developing and commercializing novel treatments for multi-drug resistant (MDR) bacterial infections.
Website: https://sperotherapeutics.com/
As a multi-asset, clinical-stage biopharmaceutical company, Spero Therapeutics is focused on identifying, developing and commercializing novel treatments for multi-drug resistant (MDR) bacterial infections.
